Hypertriglyceridemic VLDL decreases plasminogen binding to endothelial cells and surface-localized fibrinolysis.

Li, X N; Koons, J C; Benza, R L; Parks, J M; Varma, V K; Bradley, W A; Gianturco, S H; Taylor, K B; Grammer, J R; Tabengwa, E M; Booyse, F M

Li, X N; Koons, J C; Benza, R L; Parks, J M; Varma, V K; Bradley, W A; Gianturco, S H; Taylor, K B; Grammer, J R; Tabengwa, E M; Booyse, F M.

Affiliation

Li XN; Department of Medicine, University of Alabama at Birmingham 35294-2170, USA.

Biochemistry ; 35(19): 6080-8, 1996 May 14.

Article in En | MEDLINE | ID: mdl-8634250

Subject(s)

Endothelium, Vascular/metabolism; Fibrinolysis; Hypertriglyceridemia/blood; Lipoproteins, VLDL/blood; Plasminogen/metabolism; Cell Line; Endothelium, Vascular/cytology; Humans; Iodine Radioisotopes; Kinetics; Protein Binding

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Plasminogen / Endothelium, Vascular / Hypertriglyceridemia / Fibrinolysis / Lipoproteins, VLDL Limits: Humans Language: En Journal: Biochemistry Year: 1996 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links